company tower banner
Xelia Company Logo

Xelia Vancomycin Hydrochloride (Copenhage)

Xelia Vancomycin Hydrochloride (Copenhage) is a glycopeptide antibiotic active against a wide variety of Gram-positive bacteria, including Clostridium difficile, methicillin resistant (MRSA) and sensitive strains of Staphylococcus aureus (MRSA) and Streptococci.

Functions: Anti-Microbial Agent, Antibiotic

Dosage Form: Capsules

Certifications & Compliance: European Pharmacopeia (Ph. Eur.), FDA Compliant, GMP, United States Pharmacopeia (USP)

  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Pharma & Nutraceuticals Functions

Features & Benefits

Features

Product grades : Sterile, non-micronized Non-sterile, non-micronized
Manufacturing site: Xellia Pharmaceuticals ApS, Copenhagen, Denmark
Release site : Xellia Pharmaceuticals ApS, Copenhagen, Denmark
Site registered: EU GMP issued by Danish Medicines Agency, US FDA

Applications & Uses

Dosage Form
Applications

Administered systemically as intravenous infusions and as capsules for oral administration. IV form can also be used
orally for the treatment of Clostridium difficile infections.

Properties

Physical Form

Regulatory & Compliance

Compliance

Ph. Eur.
USP

Regulatory documentation

EU Drug Master File (DMF)/Certificate of Suitability (CEP)
US Drug Master File (DMF)
Letter of Access (LoA)

Packaging & Availability

Packaging sizes

Sterile, non-micronized
0.5 kgA*
3 kgA*
8 kgA*
Non-sterile, non-micronized
0.5 kgA*
3 kgA*
8 kgA*
10 kgA*

Packaging material

Sterile, non-micronized
Primary: Aluminum containers with PE insert
and polypropylene lid
Secondary: Polystyrene
Non-sterile, non-micronized
Primary: Aluminum containers with PE insert and
polypropylene lid
Secondary: Polystyrene

Storage & Handling

Shelf-life

2 years (according to EU)
3 years (according to US)

Storage conditions

Below 8°C (46°F)